Objective:To study the effects of single and multiple courses of antenatal corticosteroids on tissue water content in ovine fetuses.
Methods:After chronic catheterization of the ewes and fetuses, the ewes were randomly assigned to receive single or multiple courses of dexamethasone or placebo beginning at 104-106 or 76-78 days' gestation, respectively. In the single course groups, the ewes received dexamethansone (6 mg, n = 6) or placebo (n = 6) as four intramuscular injections every 12 hours over 48 hours. The fetal tissues were harvested for water content determination 66 hours after the first injection of dexamethasone or placebo was given. In the multiple-course groups, the ewes received the same treatment (dexamethasone, n = 10, or placebo, n = 8), once a week for 5 weeks starting at 76-78 days' gestation. In these groups, the tissues were harvested 66 hours after the first the injection of the fifth and last treatment course. In both groups, tissues were harvested at 106-107 days' gestation. Tissue water content was determined by wet-to-dry weight ratio in brain (cerebral cortex, caudate nucleus, cerebellum, midbrain, and medulla) and somatic tissues (kidney, liver, muscle, and skin).
Results:Water content in the brain regions (cerebellum and medulla) was lower (P < .05) in fetuses of dexamethasone-treated ewes than placebo-treated ewes than placebo-treated ewes after the multiple courses, but not the single course. Water content of somatic tissue was power (P < .05) in fetuses of dexamethasone-treated ewes than placebo-treated ewes after the multiple courses, and in the liver after a single course.
Conclusion:Dexamethasone treatment of ewes at 70% of gestation results in decreased regional brain water content in the fetuses after multiple but not single treatment courses, in somatic tissues (kidney, liver, muscle, and skin) after multiple courses, and in the liver after a single course.
1. Liggins GC. Premature delivery of foetal lambs infused with glucocorticoids. J. Endocrinol1969;45(4):515-523.
2.
2. Banks BA, Cnaaan A, Morgan MA, Parer JT, Merrill JD, Ballard PL, Ballard RA. Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group. Am J Obstet Gynecol1999;181(3):709-717.
3.
3. Padburgy JF, Polk DH, Ervin MG, Berry LM, Ikegami M, Jobe AH. Postnatal Cardiovascular and metabolic responses to a single intramuscular dose of betamethasone in fetal sheep born prematurely by cesarean section. Pediatr Res1995;38(5):709-715.
4.
4. Ervin MG, Berry LM, Ikegami M, Jobe AH, Padbury JF, Polk DH. Single dose fetal betamethasone administration stabilizes postnatal glomerular filtration rate and alters endocrine function in premature lambs. Pediatr Res1996;40(5):645-651.
5.
5. Berry LM, Polk DH, Ikegami M, Jobe AH, Padbury JF, Ervin MG. Preterm newborn lamb renal and cardiovascular responses after fetal or maternal antenatal betamethasone. Am J Physiol1997;272(6 Pt 2):R1972-R1979.
6.
6. Stonestreet BS, Hansen NB, Laptook AR, Oh W. Glucocorticoid accelerates renal functional maturation in fetal lambs. Early Hum Dev1983;8(3-4):331-341.
7.
7. Petershack JA, Nagaraja SC, Guillery EN. Role of glucocorticoids in the maturation of renal cortical Na + -K + -ATPase during fetal life in sheep. Am J Physiol1999;276(6 Pt 2):R1825-R1832.
8.
8. Stonestreet BS, Petersson KH, Sadowska GB, Pettigrew KD, Patlak CS. Antenatal steroids decrease blood-brain barrier permeability in the ovine fetus. Am J Physiol1999;276(2 Pt 2):R283-R289.
9.
9. Sloboda DM, Newnham JP, Challis JR. Effects of repeated maternal betamethasone administration on growth and hypothalamic-pituitary-adrenal function of the ovine fetus at term. J Endocrinol2000;165(1):79-91.
10.
10. Antenatal corticosteroids revisited: repeat courses. NIH Consensus Statement. 2000 August 17-18;17(2)1-18. Available at: http://consensus.nih.gov.
11.
11. Kutzler MA, Molnar J, Schlafer DH, Kuc RE, Davenport AP, Nathanielsz PW. Maternal dexamethasone increases endothelin-1 sensitivity and endothelin A receptor expression in ovine foetal placental arteries. Placenta2003;24(4):392-402.
12.
12. Jobe AH, Newnham J, Willet K, Sly P, Ikegami M. Fetal versus maternal and gestational age effects of repetitive antenatal glucocorticoids. Pediatrics1998;102(5):1116-1125.
13.
13. Ikegami M, Jobe AH, Newnham J, Polk DH, Willet KE, Sly P. Repetitive prenatal glucocorticoids improve lung function and decrease growth in preterm lambs. Am J Respir Crit Care Med1997;156(1):178-184.
14.
14. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci2001;19(4):415-425.
15.
15. Huang WL, Beazley LD, Quinlivan JA, Evans SF, Newnham JP, Dunlop SA. Effect of corticosteroids on brain growth in fetal sheep. Obstet Gynecol1999;94(2):213-218.
16.
16. Dunlop SA, Archer MA, Quinlivan JA, Beazley LD, Newnham JP. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med1997;6(6):309-313.
17.
17. Yamada K, Bremer AM, West CR. Effects of dexamethasone on tumor-induced brain edema and its distribution in the brain of monkeys. J Neurosurg1979;50(3):361-367.
18.
18. Sztriha L, Joo F, Szerdahelyi P, Eck E, Koltai M. Effects of dexamethasone on brain edema induced by kainic acid seizures. Neuroscience1986;17(1):107-114.
19.
19. Reid AC, Teasdale GM, McCulloch J. Hormonal influence on water permeability across the blood-brain barrier. Clin Exp Neurol1983;19:50-53.
20.
20. Reid AC, Teasdale GM, McCulloch J. The effects of dexamethasone administration and withdrawal on water permeability across the blood-brain barrier. Ann Neurol1983;13(1):28-31.
21.
21. De Souza SW, Dobbing J. Cerebral oedema in developing brain. 3. Brain water and electrolytes in immature asphyxiated rats treated with dexamethasone. Biol Neonate1973;22(5):388-397.
22.
22. Stonestreet BS, Elitt CM, Markowitz J, Petersson KH, Sadowska GB. Effects of antanatal corticosteroids on regional brain and non-neural tissue water content in the ovine fetus. J Soc Gynecol Investig2003;10(2):59-66.
23.
23. Ballabh P, Lo ES, Kumari J, Cooper TB, Zervoudakis I, Auld PA, Kraus AN. Pharmacokinetics of betamethasone in twin and singleton pregnancy. Clin Pharmacol Ther2002;71(1):39-45.
24.
24. Turrentine MA, Ramirez MM. Adverse perinatal events and subsequent cesarean rate. Obstet Gynecol1999;94(2):185-188.
25.
25. Al-Yatama MK, Al Essa M, Omu AE, Al-Shamali I, Egbase P, Rashwan N. Effect of repeated doses of dexamethasone on the incidence and severity of respiratory distress syndrome in multifetal gestation between 24 and 34 weeks. Gynecol Obstet Invest2001;52(1):26-33.
26.
26. Stonestreet BS, Le E, Berard DJ. Circulatory and metabolic effects of beta-adrenergic blockade in the hyperinsulinemic ovine fetus. Am J Physiol1993;265(4 Pt 2):H1098-H1106.
27.
27. Stonestreet BS, Patlak CS, Pettigrew KD, Reilly CB, Cserr HF. Ontogeny of blood-brain barrier function in ovine fetuses, lambs, and adults. Am J Physiol1996;271(6 Pt 2):R1594-R1601.
28.
28. Stonestreet BS, Sadowska GB, McKnight AJ, Patalk C, Petersson KH. Exogenous and endogenous corticosteroids modulate blood-brain barrier development in the ovine fetus. Am J Physiol Regul Integr Comp Physiol2000;279(2):R468-R477.
29.
29. Mcgowan JE, Sysyn G, Petersson KH, et al. Effect of dexamethasone treatment on maturational changes in the NMDA receptor in sheep brain. J Neurosci2000;20(19):7424-7429.
30.
30. Kerzner LS, Stonestreet BS, Wu KY, Sadowska G, Malee MP. Antenatal dexamethasone: Effect on ovine placental 11beta-hydroxysteroid dehydrogenase type 2 expression and fetal growth. Pediatr Res2002;52(5):706-712.
31.
31. Hai CM, Sadowska G, Francois L, Stonestreet BS. Maternal dexamethasone treatment alters myosin isoform expression and contractile dynamics in fetal arteries. Am J Physiol Heart Circ Physiol2002;283(5):H1743-H1749.
32.
32. Stonestreet BS, McKnight AJ, Sadowska GB, Patlak CS, Petersson KH. Effects of repeated courses of antenatal corticosteroids on blood-brain barrier function in early gestation ovine fetuses. Pediatr Res2000;4(2):434A-434A.
33.
33. National Institutes of Health Consensus Development Panel. Effect of corticosteroids for fetal maturation and perinatal outcomes. JAMA1995;5:413-418.
34.
34. Cserr HF, DePasquale M, Patlak CS. Regulation of brain water and electrolytes during acute hyperosmolality in rats. Am J Physiol1987;253(3 Pt 2):F522-F529.
36. Thorp JA, Jones AM, Hunt C, Clark R. The effect of multidose antenatal betamethasone on maternal and infant outcomes. Am J Obstet Gynecol2001;184(2):196-202.
37.
37. Clifton VL, Wallace EM, Smith R. Short-term effects of glucocorticoids in the human fetal-placental circulation in vitro. J Clin Endocrinol Metab2002;87(6):2838-2842.
38.
38. Milley JR. Fetal substrate uptake during increased ovine fetal cortisol concentration. Am J Physiol1996;271(1 Pt 1):E186-E191.
39.
39. Bennet L, Kozuma S, McGarrigle HH, Hanson MA. Temporal changes in fetal cardiovascular, behavioural, metabolic and endocrine responses to maternally administered dexamethasone in the late gestation fetal sheep. Br J Obstet Gynaecol1999;106(4):331-339.
40.
40. Cuthrell WV, Rose JC, Meis PJ. The effect of adrenocorticotropic hormone infusion on subsequent pituitary response in the sheep fetus. Am J Obstet Gynecol1990;163(1 Pt 1):170-174.
41.
41. Kleeman CR. The kidney in health and disease: X. CNS manifestations of disordered salt and water balance. Hosp Pract1979;14(5):59-68, 73-73.
42.
42. Strange K. Regulation of solute and water balance and cell volume in the central nervous system. J Am Soc Nephrol1992;3(1):12-27.
